de State Street Ironwood Pharmaceuticals IRWD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 37.1 M | Comprar |
8,809,601
+1,352,657
| +18% | +USD 5.21 M | ﹤0.01% | 2047 |
|
|
2026
Q1 | USD 26.2 M | Comprar |
7,456,944
+3,045,722
| +69% | +USD 12.5 M | ﹤0.01% | 2101 |
|
|
2025
Q4 | USD 14.9 M | Comprar |
4,411,222
+1,254,915
| +40% | +USD 3.26 M | ﹤0.01% | 2414 |
|
|
2025
Q3 | USD 4.13 M | Comprar |
3,156,307
+48,588
| +2% | +USD 50.3 k | ﹤0.01% | 3065 |
|
|
2025
Q2 | USD 2.23 M | Vender |
3,107,719
-390,570
| -11% | -USD 307 k | ﹤0.01% | 3268 |
|
|
2025
Q1 | USD 5.14 M | Vender |
3,498,289
-4,830,528
| -58% | -USD 11.5 M | ﹤0.01% | 2873 |
|
|
2024
Q4 | USD 36.9 M | Vender |
8,328,817
-1,591,048
| -16% | -USD 6.46 M | ﹤0.01% | 1870 |
|
|
2024
Q3 | USD 40.9 M | Comprar |
9,919,865
+677,024
| +7% | +USD 3.64 M | ﹤0.01% | 1804 |
|
|
2024
Q2 | USD 60.3 M | Vender |
9,242,841
-4,674,270
| -34% | -USD 33.1 M | ﹤0.01% | 1570 |
|
|
2024
Q1 | USD 121 M | Comprar |
13,917,111
+2,385,023
| +21% | +USD 28.9 M | 0.01% | 1184 |
|
|
2023
Q4 | USD 132 M | Vender |
11,532,088
-464,777
| -4% | -USD 4.6 M | 0.01% | 1112 |
|
|
2023
Q3 | USD 116 M | Comprar |
11,996,865
+968,376
| +9% | +USD 9.49 M | 0.01% | 1090 |
|
|
2023
Q2 | USD 117 M | Comprar |
11,028,489
+546,647
| +5% | +USD 5.88 M | 0.01% | 1107 |
|
|
2023
Q1 | USD 110 M | Vender |
10,481,842
-697,736
| -6% | -USD 7.82 M | 0.01% | 1115 |
|
|
2022
Q4 | USD 139 M | Vender |
11,179,578
-274,592
| -2% | -USD 3.11 M | 0.01% | 956 |
|
|
2022
Q3 | USD 119 M | Comprar |
11,454,170
+567,365
| +5% | +USD 6.43 M | 0.01% | 1008 |
|
|
2022
Q2 | USD 126 M | Comprar |
10,886,805
+2,589,738
| +31% | +USD 30.5 M | 0.01% | 1012 |
|
|
2022
Q1 | USD 104 M | Comprar |
8,297,067
+418,756
| +5% | +USD 4.8 M | 0.01% | 1271 |
|
|
2021
Q4 | USD 91.9 M | Comprar |
7,878,311
+445,302
| +6% | +USD 5.46 M | ﹤0.01% | 1363 |
|
|
2021
Q3 | USD 97.1 M | Comprar |
7,433,009
+627,340
| +9% | +USD 8.11 M | 0.01% | 1289 |
|
|
2021
Q2 | USD 87.6 M | Vender |
6,805,669
-574,357
| -8% | -USD 6.57 M | ﹤0.01% | 1406 |
|
|
2021
Q1 | USD 82.5 M | Vender |
7,380,026
-204,343
| -3% | -USD 2.16 M | ﹤0.01% | 1378 |
|
|
2020
Q4 | USD 86.4 M | Vender |
7,584,369
-399,881
| -5% | -USD 4.38 M | 0.01% | 1258 |
|
|
2020
Q3 | USD 71.8 M | Vender |
7,984,250
-250,313
| -3% | -USD 2.49 M | ﹤0.01% | 1185 |
|
|
2020
Q2 | USD 85 M | Comprar |
8,234,563
+2,381,926
| +41% | +USD 24.4 M | 0.01% | 1085 |
|
|
2020
Q1 | USD 59.1 M | Comprar |
5,852,637
+78,192
| +1% | +USD 919 k | 0.01% | 1152 |
|
|
2019
Q4 | USD 76.9 M | Vender |
5,774,445
-52,328
| -0.9% | -USD 577 k | 0.01% | 1223 |
|
|
2019
Q3 | USD 50 M | Vender |
5,826,773
-310,639
| -5% | -USD 3.02 M | ﹤0.01% | 1440 |
|
|
2019
Q2 | USD 67.1 M | Vender |
6,137,412
-518,598
| -8% | -USD 5.81 M | 0.01% | 1288 |
|
|
2019
Q1 | USD 75.4 M | Comprar |
6,656,010
+267,006
| +4% | +USD 2.98 M | 0.01% | 1200 |
|
|
2018
Q4 | USD 55.4 M | Vender |
6,389,004
-83,275
| -1% | -USD 956 k | 0.01% | 1296 |
|
|
2018
Q3 | USD 100 M | Vender |
6,472,279
-139,643
| -2% | -USD 2.21 M | 0.01% | 1077 |
|
|
2018
Q2 | USD 106 M | Vender |
6,611,922
-591,564
| -8% | -USD 8.75 M | 0.01% | 1001 |
|
|
2018
Q1 | USD 93.1 M | Comprar |
7,203,486
+1,438,244
| +25% | +USD 17.9 M | 0.01% | 1050 |
|
|
2017
Q4 | USD 72.4 M | Comprar |
5,765,242
+338,282
| +6% | +USD 4.42 M | 0.01% | 1207 |
|
|
2017
Q3 | USD 71.7 M | Comprar |
5,426,960
+17,821
| +0.3% | +USD 245 k | 0.01% | 1169 |
|
|
2017
Q2 | USD 85.5 M | Comprar |
5,409,139
+651,284
| +14% | +USD 9.46 M | 0.01% | 1039 |
|
|
2017
Q1 | USD 68 M | Comprar |
4,757,855
+230,972
| +5% | +USD 3.16 M | 0.01% | 1142 |
|
|
2016
Q4 | USD 58 M | Comprar |
4,526,883
+433,927
| +11% | +USD 5.48 M | 0.01% | 1182 |
|
|
2016
Q3 | USD 54.4 M | Comprar |
4,092,956
+237,259
| +6% | +USD 2.77 M | 0.01% | 1185 |
|
|
2016
Q2 | USD 42.2 M | Comprar |
3,855,697
+219,126
| +6% | +USD 2.14 M | ﹤0.01% | 1271 |
|
|
2016
Q1 | USD 33.3 M | Vender |
3,636,571
-413,761
| -10% | -USD 3.41 M | ﹤0.01% | 1379 |
|
|
2015
Q4 | USD 39.3 M | Vender |
4,050,332
-814,775
| -17% | -USD 7.87 M | ﹤0.01% | 1298 |
|
|
2015
Q3 | USD 42.5 M | Comprar |
4,865,107
+29,171
| +0.6% | +USD 272 k | ﹤0.01% | 1264 |
|
|
2015
Q2 | USD 48.8 M | Comprar |
4,835,936
+826,611
| +21% | +USD 9.6 M | 0.01% | 1282 |
|
|
2015
Q1 | USD 53.7 M | Comprar |
4,009,325
+468,329
| +13% | +USD 6.14 M | 0.01% | 1193 |
|
|
2014
Q4 | USD 45.4 M | Vender |
3,540,996
-36,329
| -1% | -USD 416 k | ﹤0.01% | 1278 |
|
|
2014
Q3 | USD 38.8 M | Comprar |
3,577,325
+254,677
| +8% | +USD 2.92 M | ﹤0.01% | 1313 |
|
|
2014
Q2 | USD 42.7 M | Vender |
3,322,648
-436,487
| -12% | -USD 4.75 M | ﹤0.01% | 1308 |
|
|
2014
Q1 | USD 38.8 M | Comprar |
3,759,135
+223,788
| +6% | +USD 2.52 M | ﹤0.01% | 1353 |
|
|
2013
Q4 | USD 34.4 M | Vender |
3,535,347
-167,636
| -5% | -USD 1.5 M | ﹤0.01% | 1410 |
|
|
2013
Q3 | USD 36.8 M | Comprar |
3,702,983
+119,363
| +3% | +USD 1.17 M | ﹤0.01% | 1325 |
|
|
2013
Q2 | USD 29.9 M | Comprar |
+3,583,620
| Nuevas | +USD 43.4 M | ﹤0.01% | 1390 |
|
Otros fondos que tienen IRWD en su cartera
SCM
Posición de State Street en IRWD: resumen de T2 2026
State Street aumentó su participación en Ironwood Pharmaceuticals (IRWD) en 18% durante T2 2026, al comprar aproximadamente USD 5.21 M y elevar la posición a 8,809,601 acciones con un valor de USD 37.1 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2047.
State Street reportó por primera vez una posición en IRWD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 139 M en T4 2022. Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank mantienen una posición en IRWD.
- Al cierre de T2 2026, State Street tenía 8,809,601 acciones de Ironwood Pharmaceuticals con un valor de USD 37.1 M.
- State Street compró 1,352,657 acciones de Ironwood Pharmaceuticals en T2 2026, por un monto estimado de USD 5.21 M.
- Ironwood Pharmaceuticals representó ﹤0.01% de la cartera de State Street en T2 2026 y fue su posición número 2047.
- State Street reportó por primera vez una posición en Ironwood Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de State Street en Ironwood Pharmaceuticals alcanzó su máximo de USD 139 M en T4 2022.
- Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank tenían Ironwood Pharmaceuticals en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.